Artal Group’s 89bio ETNB Stock Holding History

Artal Group’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-500,000	Closed	-$7.62M	–	124
2023 Q1	$7.62M	Buy	500,000 +100,000	+25%	+$1.3M	0.45%	50
2022 Q4	$5.09M	Buy	+400,000	New	+$3.6M	0.28%	61

Other funds holding ETNB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Artal Group's ETNB Position: Q2 2023 in Review

Artal Group sold out of 89bio (ETNB) in Q2 2023, closing a stake of 500,000 shares — an estimated $7.62M sold.

Artal Group first reported a position in ETNB in Q4 2022 and held it in 2 quarters. The position peaked at $7.62M in Q1 2023. 157 funds tracked by Wall St. Rank hold ETNB as of Q2 2023.

Artal Group reported no remaining 89bio position as of Q2 2023 after selling out during the quarter.
Artal Group sold 500,000 89bio shares in Q2 2023, an estimated $7.62M.
Artal Group first reported a position in 89bio in Q4 2022 and held it in 2 quarters.
Artal Group's 89bio position peaked at $7.62M in Q1 2023.
157 funds tracked by Wall St. Rank held 89bio as of Q2 2023.

Based on Artal Group's 13F filing for Q2 2023, filed 11 Aug 2023.